The Middle East and Africa Neuroendocrine Tumors market was valued at USD 122.00 Million in 2024 and is expected to reach USD 248.49 Million by 2032, growing at a CAGR of 9.3% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.